posted on 2019-10-02, 19:17authored byYongle Du, Ana Lisa Valenciano, Yumin Dai, Yi Zheng, Feng Zhang, Yan Zhang, Jason Clement, Michael Goetz, David G. I. Kingston, Maria B. Cassera
In our continuing search for novel
natural products with antiplasmodial
activity, an extract of Aniba citrifolia was found
to have good activity, with an IC50 value less than 1.25
μg/mL. After bioassay-directed fractionation, the known indolizinium
alkaloid anibamine (1) and the new indolizinium alkaloid
anibamine B (2) were isolated as the major bioactive
constituents, with antiplasmodial IC50 values of 0.170
and 0.244 μM against the drug-resistant Dd2 strain of Plasmodium falciparum. The new coumarin anibomarin A (3), the new norneolignan anibignan A (5), and
six known neolignans (7–12) were
also obtained. The structures of all the isolated compounds were determined
based on analyses of 1D and 2D NMR spectroscopic and mass spectrometric
data, and the absolute configuration of anibignan A (5) was assigned from its ECD spectrum. Evaluation of a library of
28 anibamine analogues (13–40) indicated
that quaternary charged analogues had IC50 values as low
as 58 nM, while uncharged analogues were inactive or significantly
less active. Assessment of the potential effects of anibamine and
its analogues on the intraerythrocytic stages and morphological development
of P. falciparum revealed substantial activity against
ring stages for compounds with two C-10 side chains, while those with
only one C-10 side chain exhibited substantial activity against trophozoite
stages, suggesting different mechanisms of action.